Myriad Genetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MYGN and other ETFs, options, and stocks.About MYGN
Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights.
MYGN Key Statistics
Stock Snapshot
The current Myriad Genetics(MYGN) stock price is $3.18, with a market capitalization of 304.64M. The stock trades at a price-to-earnings (P/E) ratio of -2.66.
On 2026-09-07, Myriad Genetics(MYGN) stock traded between a low of $3.15 and a high of $3.20. Shares are currently priced at $3.18, which is +0.8% above the low and -0.7% below the high.
The Myriad Genetics(MYGN)'s current trading volume is 806.17K, compared to an average daily volume of 1.48M.
During the past year, Myriad Genetics(MYGN) stock moved between $2.74 at its lowest and $8.59 at its peak.
During the past year, Myriad Genetics(MYGN) stock moved between $2.74 at its lowest and $8.59 at its peak.
MYGN News
Biotech and Pharma This Biotech Stock Got a Rare Double-Downgrade. Its Profitability Problem Just Got Worse. In this article MYGN PIPR Myriad Genetics stock was...
Piper Sandler double downgraded Myriad Genetics (MYGN) to Underweight from Overweight with a price target of $2, down from $5.45. Piper does not believe Myriad’...
Myriad Genetics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst David Westenberg from Piper Sandler downgraded the rating...
Analyst ratings
56%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.